Mark T. Iwicki - Sep 14, 2022 Form 3 Insider Report for Third Harmonic Bio, Inc. (THRD)

Role
Director
Signature
/s/ Robert Ho, Attorney-in-Fact
Stock symbol
THRD
Transactions as of
Sep 14, 2022
Transactions value $
$0
Form type
3
Date filed
9/14/2022, 06:08 PM
Previous filing
Jun 29, 2022
Next filing
Oct 27, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding THRD Common Stock 129K Sep 14, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding THRD Stock Option (right to buy) Sep 14, 2022 Common Stock 4.3K $1.45 Direct F2
holding THRD Stock Option (right to buy) Sep 14, 2022 Common Stock 35.4K $9.22 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Certain amount of the shares are subject to forfeiture.
F2 6.25% of the total shares vested on February 24, 2022, and thereafter 6.25% of the total shares underlying the award shall vest in equal quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
F3 6.25% vest in quarterly installments over the 4-year period commencing on February 17, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.